1. Home
  2. PGEN vs KRNY Comparison

PGEN vs KRNY Comparison

Compare PGEN & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • KRNY
  • Stock Information
  • Founded
  • PGEN 1998
  • KRNY 1884
  • Country
  • PGEN United States
  • KRNY United States
  • Employees
  • PGEN N/A
  • KRNY N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • KRNY Savings Institutions
  • Sector
  • PGEN Health Care
  • KRNY Finance
  • Exchange
  • PGEN Nasdaq
  • KRNY Nasdaq
  • Market Cap
  • PGEN 512.5M
  • KRNY 450.4M
  • IPO Year
  • PGEN N/A
  • KRNY 2005
  • Fundamental
  • Price
  • PGEN $1.74
  • KRNY $6.21
  • Analyst Decision
  • PGEN Buy
  • KRNY Buy
  • Analyst Count
  • PGEN 5
  • KRNY 2
  • Target Price
  • PGEN $7.00
  • KRNY $7.75
  • AVG Volume (30 Days)
  • PGEN 2.0M
  • KRNY 292.9K
  • Earning Date
  • PGEN 05-13-2025
  • KRNY 04-24-2025
  • Dividend Yield
  • PGEN N/A
  • KRNY 7.02%
  • EPS Growth
  • PGEN N/A
  • KRNY N/A
  • EPS
  • PGEN N/A
  • KRNY N/A
  • Revenue
  • PGEN $3,963,000.00
  • KRNY $148,070,000.00
  • Revenue This Year
  • PGEN N/A
  • KRNY $2.70
  • Revenue Next Year
  • PGEN $420.64
  • KRNY $24.88
  • P/E Ratio
  • PGEN N/A
  • KRNY N/A
  • Revenue Growth
  • PGEN N/A
  • KRNY N/A
  • 52 Week Low
  • PGEN $0.65
  • KRNY $5.28
  • 52 Week High
  • PGEN $2.17
  • KRNY $8.59
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 51.69
  • KRNY 31.21
  • Support Level
  • PGEN $1.66
  • KRNY $6.12
  • Resistance Level
  • PGEN $1.95
  • KRNY $7.04
  • Average True Range (ATR)
  • PGEN 0.18
  • KRNY 0.19
  • MACD
  • PGEN -0.03
  • KRNY -0.06
  • Stochastic Oscillator
  • PGEN 30.36
  • KRNY 9.78

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.

Share on Social Networks: